Company Filing History:
Years Active: 1996
Title: Richard F. Schuman: Pioneer in Immunoassays
Introduction
Richard F. Schuman, based in North Potomac, MD, is a noteworthy inventor with a significant contribution to the field of immunoassays. With one patented invention, Schuman has made strides in the detection of isothiazolones, showcasing his expertise and innovative spirit.
Latest Patents
Schuman's patent, titled “Immunoassay for Isothiazolones,” focuses on a technique utilizing monoclonal antibodies that specifically react with isothiazolones, particularly 5-chloro-2-methyl-3-isothiazolone. This invention encompasses hybridomas, such as ATCC HB 11435, that produce these antibodies. Furthermore, it details methods for preparing immunogenic conjugates of isothiazolones with a macromolecule carrier, processes for generating monoclonal antibodies reactive to isothiazolones, and compositions that include monoclonal or polyclonal antibodies aimed at detecting isothiazolones.
Career Highlights
Richard F. Schuman has been instrumental in developing impactful technologies for the Rohm and Haas Company, where he applies his extensive knowledge in immunology and chemistry. His work contributes to advancements in analytical chemistry, particularly in environmental and safety applications.
Collaborations
Throughout his career, Schuman has collaborated with esteemed colleagues, including Gary L. Willingham and Chun-Hsien Huang. These partnerships have fostered an environment where innovative solutions and new methodologies are brought to the forefront, enhancing the company’s research capabilities.
Conclusion
In conclusion, Richard F. Schuman’s contributions to the field of immunoassays highlight the importance of innovation in scientific research. His patent reflects a significant advancement in the detection of isothiazolones, ensuring environmental safety and public health. Schuman's collaborative efforts and commitment to excellence continue to inspire future generations of inventors and researchers.